Your browser doesn't support javascript.
loading
HIV-1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV-1 group M.
Depatureaux, Agnès; Mesplède, Thibault; Quashie, Peter; Oliveira, Maureen; Moisi, Daniela; Brenner, Bluma; Wainberg, Mark.
Affiliation
  • Depatureaux A; McGill AIDS Center, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
  • Mesplède T; McGill AIDS Center, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
  • Quashie P; McGill AIDS Center, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
  • Oliveira M; McGill AIDS Center, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
  • Moisi D; McGill AIDS Center, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
  • Brenner B; McGill AIDS Center, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
  • Wainberg M; McGill AIDS Center, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
J Int AIDS Soc ; 17(4 Suppl 3): 19738, 2014.
Article in En | MEDLINE | ID: mdl-25397483
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Int AIDS Soc Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2014 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Int AIDS Soc Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2014 Type: Article Affiliation country: Canada